SensoGenic (867865)

  https://cordis.europa.eu/project/id/867865

  Horizon 2020 (2014-2020)

  SensoGenic: empower food allergy sufferers and their families with the freedom to enjoy eating safely everywhere & anytime

  SME instrument (EIC-SMEInst-2018-2020)

  biosensors  ·  food technology  ·  food allergy  ·  emergency medicine  ·  proteins

  2019-03-01 Start Date (YY-MM-DD)

  2019-08-31 End Date (YY-MM-DD)

  € 71,429 Total Cost

  Description

SensoGenic Ltd. is a science and technology company based in Israel, that is developing food allergens biosensor which is a portable, handheld, a digital diagnostic analyser for consumers. https://www.sensogenic.com Today, there isn't any consumer solution in the market that address food allergens detection. The solution for food manufactures is very long and expensive laboratory tests. SensoGenic will focus on consumer product that detects milk and eggs simultaneously in relevant food and concentrations. After successfully validating the POC of SensoGenic, based on company own research and experiments as well as supportive academic articles, the team can confirm the capability of its breakthrough IP as unique approach for allergens proteins detection. By pursuing the present feasibility study, the management team aims to improve its understanding of international market conditions and the associated risks that need to be considered as the company develops a deeper business plan for rolling out, and scaling up SensoGenic as a marketable innovative solution. SME Instrument Phase-1 and Phase-2 will be extremely beneficial in helping the company to accelerate development and market penetration of the solution in target segments, boosting the company’s growth to 100 employees and €26,000,000 revenues by 2025.

  Complicit Organisations

1 Israeli organisation participates in SensoGenic.